not losing weight on semaglutide week 2 Why Am I Semaglutide? Woman shares journey of weight

Users inject it subcutaneously, and within days to weeks, the skin takes on a deep, uniform tan

Baseline liver enzyme assessment is reasonable for patients with: Pre-existing liver disease or elevated baseline transaminases Metabolic syndrome or clinical features suggesting MASLD Concurrent use of other potentially hepatotoxic medications Obesity (BMI 30 kg/m) with additional metabolic risk factors History of excessive alcohol consumption For patients with abnormal baseline liver enzymes, periodic monitoring every 3-6 months during the first year of therapy allows clinicians to assess treatment response and detect any unexpected changes

Regarding the serum GLP-1 and insulin levels, the levels of GLP-1 in T2DM and T2DM + sham group were significantly lower than NC group, compared with the T2DM + sham group, GLP-1 levels increased dramatically in T2DM + RYGB and T2DM + EX-4 groups (Figure 6H)

Patients with a history of alcohol use disorder should also abstain, as even small amounts may trigger relapse, and the metabolic complications of resumed heavy drinking would be particularly detrimental in the context of diabetes or obesity management